Hospital-acquired (nosocomial) pneumonia
Definitions
- Hospital-acquired pneumonia (HAP): pneumonia that develops ≥ 48 hours after admission and was not incubating at the time of admission.
- Ventilator-associated pneumonia (VAP): a subtype that develops ≥ 48 hours after endotracheal intubation.
- Early-onset (< 5 days in hospital): usually community-type organisms with a better prognosis; late-onset (≥ 5 days): multidrug-resistant (MDR) organisms, higher mortality.
- HAP is the second most common hospital infection and the leading infectious cause of death in hospital; VAP occurs in about 10–25% of ventilated patients, mortality 20–50%.
Pathogens
- Gram-negative bacilli (about 60%): Pseudomonas aeruginosa, Enterobacteriaceae (Klebsiella, E. coli, Enterobacter, Serratia — often ESBL or carbapenemase producers), Acinetobacter baumannii, Stenotrophomonas.
- Staphylococcus aureus, including MRSA.
- Early-onset: S. pneumoniae, H. influenzae, MSSA, sensitive Enterobacteriaceae.
- Rarely: Legionella (contaminated hospital water), anaerobes (aspiration), fungi (Candida in sputum is usually colonisation, not pneumonia), viruses (influenza, RSV, SARS-CoV-2 outbreaks).
Risk factors
Mechanism: the oropharynx and stomach become colonised by hospital Gram-negatives within days → microaspiration of secretions (in VAP, leaking around the endotracheal tube cuff and from the biofilm on the tube) → pneumonia when host defences are weak.
Risk factors for MDR pathogens
- IV antibiotics in the previous 90 days (the most important).
- Septic shock or need for ventilation at the time of HAP; ARDS before VAP; ≥ 5 days in hospital before VAP; acute renal replacement therapy.
- High local prevalence of resistant organisms (unit > 10–20% MRSA or resistant Gram-negatives); known colonisation.
Clinical features and diagnosis
- Diagnosis: new or progressive infiltrate on chest imaging + at least two of: fever > 38 °C (or hypothermia), leukocytosis or leukopenia, purulent secretions, worsening oxygenation.
- In the ventilated patient: more and purulent tracheal secretions, rising oxygen requirement or PEEP, fever, haemodynamic instability.
- Differential diagnosis: atelectasis, pulmonary oedema, ARDS, PE, aspiration pneumonitis, drug reaction, pulmonary haemorrhage.
- Before antibiotics: lower respiratory tract samples for Gram stain and (semi)quantitative culture — sputum, endotracheal aspirate, or bronchoscopic/blind BAL or protected brush; blood cultures (2 sets); pleural fluid if effusion; MRSA nasal swab (a negative result helps stop anti-MRSA treatment); Legionella and pneumococcal urinary antigen in selected cases.
- Procalcitonin and CPIS (Clinical Pulmonary Infection Score) help, but the decision is clinical.
Empirical treatment (ERS/ESICM/ESCMID/ALAT algorithm)
- Always follow the local antibiogram of the hospital or ICU.
- De-escalate within 48–72 h to a narrow agent according to cultures, or stop if pneumonia is excluded.